Mobia Medical Statistics
Total Valuation
Mobia Medical has a market cap or net worth of $456.51 million. The enterprise value is $450.00 million.
| Market Cap | 456.51M |
| Enterprise Value | 450.00M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mobia Medical has 33.25 million shares outstanding.
| Current Share Class | 33.25M |
| Shares Outstanding | 33.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 0.42% |
| Float | 22.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.87 |
| Forward PS | n/a |
| PB Ratio | 37.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.06, with a Debt / Equity ratio of 4.09.
| Current Ratio | 6.06 |
| Quick Ratio | 5.12 |
| Debt / Equity | 4.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -48.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -85.81% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $230,263 |
| Profits Per Employee | -$320,869 |
| Employee Count | 167 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Mobia Medical has paid $4,450 in taxes.
| Income Tax | 4,450 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 58.03 |
| Average Volume (20 Days) | 237,469 |
Short Selling Information
The latest short interest is 344,480, so 1.04% of the outstanding shares have been sold short.
| Short Interest | 344,480 |
| Short Previous Month | 330,858 |
| Short % of Shares Out | 1.04% |
| Short % of Float | 1.56% |
| Short Ratio (days to cover) | 1.30 |
Income Statement
In the last 12 months, Mobia Medical had revenue of $38.45 million and -$53.59 million in losses. Loss per share was -$23.53.
| Revenue | 38.45M |
| Gross Profit | 31.27M |
| Operating Income | -53.00M |
| Pretax Income | -53.58M |
| Net Income | -53.59M |
| EBITDA | -52.82M |
| EBIT | -53.00M |
| Loss Per Share | -$23.53 |
Balance Sheet
The company has $55.73 million in cash and $49.21 million in debt, with a net cash position of $6.51 million or $0.20 per share.
| Cash & Cash Equivalents | 55.73M |
| Total Debt | 49.21M |
| Net Cash | 6.51M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 12.03M |
| Book Value Per Share | -167.20 |
| Working Capital | 59.88M |
Cash Flow
In the last 12 months, operating cash flow was -$53.70 million and capital expenditures -$383,411, giving a free cash flow of -$46.06 million.
| Operating Cash Flow | -53.70M |
| Capital Expenditures | -383,411 |
| Depreciation & Amortization | 151,657 |
| Net Borrowing | n/a |
| Free Cash Flow | -46.06M |
| FCF Per Share | -$1.39 |
Margins
Gross margin is 81.32%, with operating and profit margins of -137.83% and -139.35%.
| Gross Margin | 81.32% |
| Operating Margin | -137.83% |
| Pretax Margin | -139.34% |
| Profit Margin | -139.35% |
| EBITDA Margin | -137.37% |
| EBIT Margin | -137.83% |
| FCF Margin | n/a |
Dividends & Yields
Mobia Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -11.74% |
| FCF Yield | -10.09% |
Analyst Forecast
The average price target for Mobia Medical is $20.00, which is 45.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 45.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 53.69% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Mobia Medical has an Altman Z-Score of -4.22. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.22 |
| Piotroski F-Score | n/a |